The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinicopathologic features of patients with breast cancer under teatment of bisphosphonate at the time of diagnosis: Retrospective analysis.
D. S. Dede
No relevant relationships to disclose
C. Arslan
No relevant relationships to disclose
S. Aksoy
No relevant relationships to disclose
O. Dizdar
No relevant relationships to disclose
E. Dogan
No relevant relationships to disclose
A. Alkan
No relevant relationships to disclose
I. H. Gullu
No relevant relationships to disclose
Y. Y. Ozisik
No relevant relationships to disclose
K. Altundag
No relevant relationships to disclose